UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000019821
Receipt No. R000022830
Scientific Title Development of novel miniscrew.
Date of disclosure of the study information 2015/11/30
Last modified on 2020/11/20 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Development of novel miniscrew.
Acronym Development of novel miniscrew.
Scientific Title Development of novel miniscrew.
Scientific Title:Acronym Development of novel miniscrew.
Region
Japan

Condition
Condition Malocclusion
Classification by specialty
Dental medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Nowadays, orthodontic miniscrew implants were newly developed and have been well accepted in all over the world because this provides absolute anchorage without patient's compliance. Miniscrew can provide stable anchorage for various type of tooth movements, including intrusion, retraction, and protraction, resulting in achievements of ideal occlusion and facial balance. However, the clinical use of miniscrew implants especially for long time, accompanies some risks and complications. Screw failure is one of the most undesirable problems, and a recent review found an overall failure rate of 23.2%. This rate is significantly higher than the failure rate of dental implants for prosthetic restorations. Truly, in clinical orthodontics, several cases showed one or more experiences of screw failure, which affects treatment outcome and duration. Rarely, failed miniscrew could be a risk factor for pulmonary aspiration. Therefore, increasing the success rate of miniscrew implants in clinical orthodontics is an urgent issue. In this study, the aim is to develop a novel miniscrew with higher success rate, which contributes to a safe and effective orthodontic treatment.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Stability of miniscrew implants (at 1-3 months after implantation)
Key secondary outcomes The tightening torque and loosening torque of miniscrew implants (after implantation immediately)

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Novel developed miniscrew (NDM) group: patients with implantation of NDM between the date of approval and March 2020.
Duration of interventional study: During multi-bracket treatment (approximately 2-3 years)
Number of intervention: Implant the required number of NDM needed to treat. However, the upper limit per patient to the six.
Interventions/Control_2 Conventional miniscrew (CM) group: patients treated with CM between the date of April 2008 and September 2015.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
12 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients will have been diagnosed with the application of miniscrew implants between the date of approval and March 2020.
Key exclusion criteria ・Unmanageable severe systemic disease
・Unmanageable bleeding disorder, Uncooperative patients without motivation
・Drugs, alcohol, nicotine addiction patients, and dysfunction of treatment resistance for long time
・Xerostomia
・Opportunistic immunodeficiency and leukocyte dysfunction
・Diseases requiring a regular steroid
・Unmanageable endocrine disease
・Hypersensitivity to titanium/ titanium alloy
・Abnormal wound healing function
・Administered bisphosphonates
・Not in good general condition
・The implanted area has some problems such as inflammation, tumors, cysts, lesions, and trauma
Target sample size 400

Research contact person
Name of lead principal investigator
1st name Eiji
Middle name
Last name Tanaka
Organization Tokushima University Graduate School
Division name Department of Orthodontics and Dentofacial Orthopedics, Institute of Biomedical Sciences
Zip code 7708504
Address 3-18-15, Kuramotocho, Tokushima, Tokushima, Japan
TEL 088-633-7357
Email etanaka@tokushima-u.ac.jp

Public contact
Name of contact person
1st name Keiichiro
Middle name
Last name Watanabe
Organization Tokushima University Graduate School
Division name Department of Orthodontics and Dentofacial Orthopedics, Institute of Biomedical Sciences
Zip code 7708504
Address 3-18-15, Kuramotocho, Tokushima, Tokushima, Japan
TEL 088-633-7357
Homepage URL
Email nabe@tokushima-u.ac.jp

Sponsor
Institute Department of Orthodontics and Dentofacial Orthopedics, Institute of Biomedical Sciences, Tokushima University Graduate School
Institute
Department

Funding Source
Organization BIODENT CORPORATION
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization IRB, Tokushima University Hospital
Address Kuramoto-cho 2-50-1, Tokushima, Tokushima
Tel 0886339294
Email awachiken@tokushima-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 11 Month 30 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 11 Month 30 Day
Date of IRB
2015 Year 11 Month 30 Day
Anticipated trial start date
2015 Year 12 Month 01 Day
Last follow-up date
2020 Year 03 Month 31 Day
Date of closure to data entry
2020 Year 08 Month 31 Day
Date trial data considered complete
2020 Year 08 Month 31 Day
Date analysis concluded
2020 Year 10 Month 31 Day

Other
Other related information

Management information
Registered date
2015 Year 11 Month 17 Day
Last modified on
2020 Year 11 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022830